Zhenyu Jiang

Prof. Dr. Zhenyu Jiang


Research Focus & Metrics

Academic Career Length

3Years (2024-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
3 September 2024 in IEEE Journal of Biomedical and Health Informatics
Verified
Journal Article
Closed access
ZJZhenyu Jiang
Zhenyu Jiang
PDPingjian Ding
Pingjian Ding
CSCong Shen
Cong Shen
XDXiaopeng Dai
Xiaopeng Dai
Drug-drug interaction (DDI) can trigger many adverse effects in patients and has emerged as a threat to medicine and public health. Therefore, it is important to predict potential drug interactions since it can provide combination strategies of drugs for systematic and effective treatment. Existing deep learning-based methods often rely on DDI functional networks, or use them as an important part of the model information source. However, it is difficult to discover the interactions of a new drug. To address the above limitations, we propose a geometric molecular graph representation learning model (Mol-DDI) for DDI prediction based on the basic assumption that structure determines function. Mol-DDI only considers the covalent and non-covalent bond information of molecules, then it uses the pre-training idea of large-scale models to learn drug molecular representations and predict drug interactions during the fine-tuning process. Experimental results show that the Mol-DDI model outperforms others on the three datasets and performs better in predicting new drug interaction experiments.

17 June 2024 in PLOS ONE
Verified
Journal Article
Open access
PDF file
ZJZhenyu Jiang
Zhenyu Jiang
ZGZhi Gong
Zhi Gong
ZJZhenyu Jiang
Zhenyu Jiang
HZHongyan Zhang
Hongyan Zhang
PDPingjian Ding
Pingjian Ding
CSCong Shen
Cong Shen
Drug-drug interaction (DDI) is the combined effects of multiple drugs taken together, which can either enhance or reduce each other’s efficacy. Thus, drug interaction analysis plays an important role in improving treatment effectiveness and patient safety. It has become a new challenge to use computational methods to accelerate drug interaction time and reduce its cost-effectiveness. The existing methods often do not fully explore the relationship between the structural information and the functional information of drug molecules, resulting in low prediction accuracy for drug interactions, poor generalization, and other issues. In this paper, we propose a novel method, which is a deep graph contrastive learning model for drug-drug interaction prediction (DeepGCL for brevity). DeepGCL incorporates a contrastive learning component to enhance the consistency of information between different views (molecular structure and interaction network), which means that the DeepGCL model predicts drug interactions by integrating molecular structure features and interaction network topology features. Experimental results show that DeepGCL achieves better performance than other methods in all datasets. Moreover, we conducted many experiments to analyze the necessity of each component of the model and the robustness of the model, which also showed promising results. The source code of DeepGCL is freely available athttps://github.com/jzysj/DeepGCL.